NISCH
Basic information
Region (hg38): 3:52455118-52493068
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NISCH gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 9 | |||||
missense | 74 | 83 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 74 | 10 | 8 |
Variants in NISCH
This is a list of pathogenic ClinVar variants found in the NISCH region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-52455654-C-G | not specified | Uncertain significance (May 11, 2022) | ||
3-52455661-T-C | not specified | Uncertain significance (Nov 17, 2022) | ||
3-52455693-G-A | not specified | Uncertain significance (Jan 17, 2024) | ||
3-52457855-C-G | not specified | Uncertain significance (Oct 19, 2024) | ||
3-52457856-A-G | not specified | Uncertain significance (Aug 14, 2024) | ||
3-52458800-G-A | not specified | Uncertain significance (Feb 14, 2023) | ||
3-52458843-A-G | not specified | Uncertain significance (Apr 07, 2022) | ||
3-52470861-G-T | not specified | Uncertain significance (Nov 19, 2022) | ||
3-52470877-G-A | not specified | Uncertain significance (Feb 07, 2023) | ||
3-52471848-C-T | Likely benign (Jan 09, 2018) | |||
3-52471930-G-C | not specified | Uncertain significance (Jul 22, 2024) | ||
3-52471936-G-A | not specified | Uncertain significance (Jun 26, 2023) | ||
3-52471937-G-C | not specified | Uncertain significance (Jun 11, 2024) | ||
3-52472349-A-G | not specified | Uncertain significance (Jan 08, 2024) | ||
3-52472351-C-T | not specified | Uncertain significance (Dec 19, 2022) | ||
3-52472358-C-T | not specified | Uncertain significance (Jul 12, 2023) | ||
3-52473777-C-T | not specified | Uncertain significance (Apr 15, 2024) | ||
3-52473778-G-A | Benign (Mar 29, 2018) | |||
3-52473782-C-G | not specified | Uncertain significance (Mar 20, 2024) | ||
3-52473822-C-T | not specified | Uncertain significance (Oct 08, 2024) | ||
3-52476468-T-A | not specified | Uncertain significance (Mar 02, 2023) | ||
3-52476505-T-C | not specified | Uncertain significance (Jun 11, 2021) | ||
3-52476510-G-T | not specified | Uncertain significance (May 11, 2022) | ||
3-52476525-G-A | not specified | Likely benign (Jun 27, 2022) | ||
3-52476532-C-G | not specified | Uncertain significance (Apr 12, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NISCH | protein_coding | protein_coding | ENST00000345716 | 21 | 37954 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.994 | 0.00557 | 125723 | 0 | 24 | 125747 | 0.0000954 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.30 | 741 | 939 | 0.789 | 0.0000620 | 9769 |
Missense in Polyphen | 182 | 299.18 | 0.60833 | 3126 | ||
Synonymous | -0.847 | 447 | 425 | 1.05 | 0.0000306 | 3116 |
Loss of Function | 5.95 | 10 | 59.5 | 0.168 | 0.00000264 | 707 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000276 | 0.000276 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000124 | 0.000123 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Acts either as the functional imidazoline-1 receptor (I1R) candidate or as a membrane-associated mediator of the I1R signaling. Binds numerous imidazoline ligands that induces initiation of cell-signaling cascades triggering to cell survival, growth and migration. Its activation by the agonist rilmenidine induces an increase in phosphorylation of mitogen-activated protein kinases MAPK1 and MAPK3 in rostral ventrolateral medulla (RVLM) neurons that exhibited rilmenidine-evoked hypotension (By similarity). Blocking its activation with efaroxan abolished rilmenidine-induced mitogen-activated protein kinase phosphorylation in RVLM neurons (By similarity). Acts as a modulator of Rac-regulated signal transduction pathways (By similarity). Suppresses Rac1-stimulated cell migration by interacting with PAK1 and inhibiting its kinase activity (By similarity). Also blocks Pak-independent Rac signaling by interacting with RAC1 and inhibiting Rac1-stimulated NF-kB response element and cyclin D1 promoter activation (By similarity). Inhibits also LIMK1 kinase activity by reducing LIMK1 'Tyr-508' phosphorylation (By similarity). Inhibits Rac-induced cell migration and invasion in breast and colon epithelial cells (By similarity). Inhibits lamellipodia formation, when overexpressed (By similarity). Plays a role in protection against apoptosis. Involved in association with IRS4 in the enhancement of insulin activation of MAPK1 and MAPK3. When overexpressed, induces a redistribution of cell surface ITGA5 integrin to intracellular endosomal structures. {ECO:0000250, ECO:0000269|PubMed:10882231, ECO:0000269|PubMed:12868002, ECO:0000269|PubMed:15028619, ECO:0000269|PubMed:15028621, ECO:0000269|PubMed:15475348}.;
Recessive Scores
- pRec
- 0.154
Intolerance Scores
- loftool
- 0.554
- rvis_EVS
- -2.31
- rvis_percentile_EVS
- 1.2
Haploinsufficiency Scores
- pHI
- 0.107
- hipred
- Y
- hipred_score
- 0.671
- ghis
- 0.567
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.901
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nisch
- Phenotype
- growth/size/body region phenotype; craniofacial phenotype; skeleton phenotype; respiratory system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hearing/vestibular/ear phenotype; immune system phenotype;
Gene ontology
- Biological process
- glucose metabolic process;apoptotic process;regulation of blood pressure;Rac protein signal transduction;actin cytoskeleton organization;negative regulation of cell migration;regulation of synaptic transmission, GABAergic;norepinephrine secretion
- Cellular component
- cytoplasm;early endosome;cytosol;plasma membrane;membrane;recycling endosome
- Molecular function
- integrin binding;protein binding;protein kinase binding;phosphatidylinositol binding;identical protein binding